These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 24587670)

  • 1. Targeting cell death signaling in colorectal cancer: current strategies and future perspectives.
    Koehler BC; Jäger D; Schulze-Bergkamen H
    World J Gastroenterol; 2014 Feb; 20(8):1923-34. PubMed ID: 24587670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia regulates TRAIL sensitivity of colorectal cancer cells through mitochondrial autophagy.
    Knoll G; Bittner S; Kurz M; Jantsch J; Ehrenschwender M
    Oncotarget; 2016 Jul; 7(27):41488-41504. PubMed ID: 27166192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic triterpenoids inhibit growth, induce apoptosis and suppress pro-survival Akt, mTOR and NF-{kappa}B signaling proteins in colorectal cancer cells.
    Gao X; Deeb D; Hao J; Liu Y; Arbab AS; Dulchavsky SA; Gautam SC
    Anticancer Res; 2010 Mar; 30(3):785-92. PubMed ID: 20392997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin's lymphoma B cells.
    Jacquemin G; Granci V; Gallouet AS; Lalaoui N; Morlé A; Iessi E; Morizot A; Garrido C; Guillaudeux T; Micheau O
    Haematologica; 2012 Jan; 97(1):38-46. PubMed ID: 21933852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
    Zhang L; Fang B
    Cancer Gene Ther; 2005 Mar; 12(3):228-37. PubMed ID: 15550937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Recombinant Circularly Permuted Tumor Necrosis Factor (TNF)-Related Apoptosis-Inducing Ligand (TRAIL) (Recombinant Mutant Human TRAIL) in Combination with 5-Fluorouracil in Human Colorectal Cancer Cell Lines HCT116 and SW480.
    Sun T; Zhu T; Liang X; Yang S; Zhao R
    Med Sci Monit; 2018 Apr; 24():2550-2561. PubMed ID: 29695684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis and chemo-resistance in colorectal cancer.
    Prabhudesai SG; Rekhraj S; Roberts G; Darzi AW; Ziprin P
    J Surg Oncol; 2007 Jul; 96(1):77-88. PubMed ID: 17443738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel coordination complex of platinum (PT) induces cell death in colorectal cancer by altering redox balance and modulating MAPK pathway.
    Al-Khayal K; Vaali-Mohammed MA; Elwatidy M; Bin Traiki T; Al-Obeed O; Azam M; Khan Z; Abdulla M; Ahmad R
    BMC Cancer; 2020 Jul; 20(1):685. PubMed ID: 32703189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting apoptosis pathways in childhood malignancies.
    Fulda S
    Cancer Lett; 2013 May; 332(2):369-73. PubMed ID: 21036468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obatoclax, a Pan-BCL-2 Inhibitor, Downregulates Survivin to Induce Apoptosis in Human Colorectal Carcinoma Cells Via Suppressing WNT/β-catenin Signaling.
    Or CR; Huang CW; Chang CC; Lai YC; Chen YJ; Chang CC
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32150830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling.
    Koehler BC; Jassowicz A; Scherr AL; Lorenz S; Radhakrishnan P; Kautz N; Elssner C; Weiss J; Jaeger D; Schneider M; Schulze-Bergkamen H
    BMC Cancer; 2015 Nov; 15():919. PubMed ID: 26585594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low extracellular pH augments TRAIL-induced apoptotic death through the mitochondria-mediated caspase signal transduction pathway.
    Lee YJ; Song JJ; Kim JH; Kim HR; Song YK
    Exp Cell Res; 2004 Feb; 293(1):129-43. PubMed ID: 14729063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death.
    Park SJ; Jo DS; Jo SY; Shin DW; Shim S; Jo YK; Shin JH; Ha YJ; Jeong SY; Hwang JJ; Kim YS; Suh YA; Chang JW; Kim JC; Cho DH
    Oncotarget; 2016 Oct; 7(40):65957-65967. PubMed ID: 27602754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells.
    Park KJ; Lee SH; Kim TI; Lee HW; Lee CH; Kim EH; Jang JY; Choi KS; Kwon MH; Kim YS
    Cancer Res; 2007 Aug; 67(15):7327-34. PubMed ID: 17671202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of tumour necrosis factor-related apoptosis-inducing ligand death receptors in sporadic and hereditary colorectal tumours: potential targets for apoptosis induction.
    Koornstra JJ; Jalving M; Rijcken FE; Westra J; Zwart N; Hollema H; de Vries EG; Hofstra RW; Plukker JT; de Jong S; Kleibeuker JH
    Eur J Cancer; 2005 May; 41(8):1195-202. PubMed ID: 15911244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of NF-kappaB signaling by quinacrine is cytotoxic to human colon carcinoma cell lines and is synergistic in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) or oxaliplatin.
    Jani TS; DeVecchio J; Mazumdar T; Agyeman A; Houghton JA
    J Biol Chem; 2010 Jun; 285(25):19162-72. PubMed ID: 20424169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-type-specific crosstalk between autophagy, necroptosis and apoptosis as a pharmacological target.
    Radogna F; Dicato M; Diederich M
    Biochem Pharmacol; 2015 Mar; 94(1):1-11. PubMed ID: 25562745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death.
    Meslin F; Hamaï A; Gao P; Jalil A; Cahuzac N; Chouaib S; Mehrpour M
    Cancer Res; 2007 Nov; 67(22):10910-9. PubMed ID: 18006836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax.
    LeBlanc H; Lawrence D; Varfolomeev E; Totpal K; Morlan J; Schow P; Fong S; Schwall R; Sinicropi D; Ashkenazi A
    Nat Med; 2002 Mar; 8(3):274-81. PubMed ID: 11875499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis.
    Shirjang S; Mansoori B; Asghari S; Duijf PHG; Mohammadi A; Gjerstorff M; Baradaran B
    Free Radic Biol Med; 2019 Aug; 139():1-15. PubMed ID: 31102709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.